Saltar al contenido
Merck

The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentration.

The Journal of antimicrobial chemotherapy (2003-02-04)
P David Rogers, Robert E Kramer, Janice K Crews, Russell E Lewis
RESUMEN

The ability of amphotericin B to increase intracellular calcium concentrations in human cells is associated with the toxicity of this antifungal agent. The present study was performed to determine whether amphotericin B affects the influx or efflux of calcium in Candida albicans, and whether the antifungal activity of amphotericin B is dependent upon extracellular calcium concentrations. Concentration-response studies demonstrated that the addition of up to 1 mM EGTA to standard growth medium, with a more than 4000-fold decrease in extracellular calcium concentration, had no effect on the activity of amphotericin B against C. albicans. Amphotericin B did affect the kinetics of calcium influx acutely (< or =10 min), but had no net effect on long-term (1-24 h) calcium accumulation. Calcium efflux was also not affected by amphotericin B. These results indicate that, unlike its effects on mammalian cells, the toxicity of amphotericin B against C. albicans is not dependent upon increased movement of calcium across the cell membrane or the presence of extracellular calcium.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anfotericina B from Streptomyces sp., ~80% (HPLC), powder